Skip to content

Clinical trials

Enrolling by invitation Phase 1 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Enrolling by invitation Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20222
20234
202415
202530
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital5
Changchun BCHT Biotechnology Co.3
Affiliated Hospital of Jiangnan University2
Peking University First Hospital2
Second Affiliated Hospital of Wenzhou Medical University2
Affiliated Hospital of Nanjing University of Chinese Medicine1
Anhui Provincial Hospital1
BGI, China1
Beijing Bio-Targeting Therapeutics Technology Co., Ltd1
Beijing Neurosurgical Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms4
Breast Neoplasms2
Carcinoma, Transitional Cell2
Prostatic Neoplasms2
Adenoviridae Infections1
Amyotrophic Lateral Sclerosis1
Aortic Aneurysm, Thoracoabdominal1
Carcinoma, Hepatocellular1
Colorectal Neoplasms1
Dermatitis, Atopic1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.